| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 814 |
| 1 | ASPIRIN | 313 |
| 2 | ASPIRIN 325 MG | 264 |
| 3 | ASPIRIN 81 MG | 264 |
| 4 | ASPIRIN TABLET 325MG | 263 |
| 5 | CLOPIDOGREL | 126 |
| 6 | FUROSEMIDE | 73 |
| 7 | METOPROLOL | 59 |
| 8 | METOPROLOL TARTRATE | 59 |
| 9 | LISINOPRIL | 58 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0100 |
| 1 | BENZOCAINE AND MENTHOL, UNSPECIFIED FORM | 1 | 0.0047 |
| 2 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0047 |
| 3 | RIVAROXABAN | 814 | 0.0046 |
| 4 | BENZOCAINE AND MENTHOL | 1 | 0.0046 |
| 5 | BAYER ASPIRIN EXTRA STRENGTH | 14 | 0.0039 |
| 6 | DRONEDARONE | 16 | 0.0018 |
| 7 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0018 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0016 |
| 9 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | 1 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 822 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 364 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 339 |
| 3 | Loop Diuretic [EPC] | 78 |
| 4 | Proton Pump Inhibitor [EPC] | 44 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 40 |
| 6 | beta-Adrenergic Blocker [EPC] | 39 |
| 7 | alpha-Adrenergic Blocker [EPC] | 32 |
| 8 | Sulfonylurea [EPC] | 31 |
| 9 | Insulin Analog [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 822 | 0.0023 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 339 | 0.0007 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0006 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0005 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0005 |
| 5 | alpha-Adrenergic Blocker [EPC] | 32 | 0.0004 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 364 | 0.0004 |
| 7 | Loop Diuretic [EPC] | 78 | 0.0003 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0003 |
| 9 | Nitrate Vasodilator [EPC] | 25 | 0.0003 |